RE:RE:TRX vs. CPHThe safe aspirin is already proven in a phase III and could be a 500 million to a billion dollar product, per year. They only have to solve manufacturing issues and that appears well advanced. Now they can keep control of the product and sell it themselves. Prive in billions in potential revenue over the life of the products. Asprin sales have been boominh in the UK given recent health findings one report stated, doubling in sales. They can also control marketing of TRX`s other products. and they have a $350 million warchest to acquire additional products and 2.5 times EBITDA or whathaveyou and get the superior multilple of an increaisingly strong and diversified company.